SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

10 Feb 2023 Evaluate
A fair growth of 5.37% in the revenue at Rs. 1387.30 millions was reported in the December 2022 quarter as compared to Rs. 1316.64 millions during year-ago period.A humble growth in net profit of 24.96% reported in the quarter ended December 2022 to Rs. 93.07  millions from Rs. 74.48 millions.The company reported a good operating profit of 145.42 millions compared to 124.74 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1387.30 1316.64 5.37 3701.77 3576.76 3.50 4866.46 4319.60 12.66
Other Income 21.13 3.39 523.30 50.78 41.68 21.83 51.97 105.38 -50.68
PBIDT 145.42 124.74 16.58 421.20 371.44 13.40 520.43 551.22 -5.59
Interest 0.29 5.77 -94.97 1.95 11.38 -82.86 9.61 14.94 -35.68
PBDT 145.13 118.97 21.99 419.25 360.06 16.44 510.82 536.28 -4.75
Depreciation 24.33 29.92 -18.68 72.93 89.53 -18.54 119.60 150.76 -20.67
PBT 120.80 89.05 35.65 346.32 270.53 28.02 391.22 385.52 1.48
TAX 27.73 14.57 90.32 80.74 54.17 49.05 85.61 101.15 -15.36
Deferred Tax 0.13 -0.89 -114.61 -2.36 -5.39 -56.22 -9.95 6.50 -253.08
PAT 93.07 74.48 24.96 265.58 216.36 22.75 305.61 284.37 7.47
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 10.48 9.47 10.64 11.38 10.38 9.57 10.69 12.76 -16.20

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×